The purpose of this article is to understand the way in which medical physicists take into account treatment effectiveness and safety when selecting a treatment plan, with respect to the medical prescription and the technical, human and organizational resources available. Data-gathering was based on the allo-confrontation method: 14 medical physicists from five different treatment centers commented on real treatment plans that had been drawn up by their colleagues. Results show that medical physicists have two means at their disposal to control treatment effectiveness and safety: risk avoidance and risk reduction. Risk avoidance is achieved when conceiving the treatment solution. Risk reduction occurs after the design of the plan and consists in accompanying and assisting the radiographers at the workstation where the treatment is carried out.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.apergo.2011.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Radiopharmaceutical therapy and radioembolization: Clinical guidance for medical physicists in radiation oncology.
Pract Radiat Oncol
December 2024
Northwell Health, Department of Radiology, 200 Marcus Avenue, New Hyde Park, NY 11040.
Recent advances in radiopharmaceutical therapy (RPT) and radioembolization (RE) will make these forms of therapy more prevalent in radiation oncology and nuclear medicine clinics. This article guides medical physicists in radiation oncology by summarizing current RPT and RE techniques, processes, safety, quality assurance, equipment, etc. The summarized guidance, which addresses technical considerations, may be applied broadly to develop a clinical RPT/RE program that offers multiple types of such therapies.
View Article and Find Full Text PDFPARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy.
Sci Rep
December 2024
Division of Radiation Oncology, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Aggressive breast cancers often fail or acquire resistance to radiotherapy. To develop new strategies to improve the outcome of aggressive breast cancer patients, we studied how PARP inhibition radiosensitizes breast cancer models to proton therapy, which is a radiotherapy modality that generates more DNA damage in the tumor than standard radiotherapy using photons. Two human BRCA1-mutated breast cancer cell lines and their isogenic BRCA1-recovered pairs were treated with a PARP inhibitor and irradiated with photons or protons.
View Article and Find Full Text PDFA prospectively deployed deep learning-enabled automated quality assurance tool for oncological palliative spine radiation therapy.
Lancet Digit Health
January 2025
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA. Electronic address:
Background: Palliative spine radiation therapy is prone to treatment at the wrong anatomic level. We developed a fully automated deep learning-based spine-targeting quality assurance system (DL-SpiQA) for detecting treatment at the wrong anatomic level. DL-SpiQA was evaluated based on retrospective testing of spine radiation therapy treatments and prospective clinical deployment.
View Article and Find Full Text PDFDataset for gastrointestinal tract segmentation on serial MRIs for abdominal tumor radiotherapy.
Data Brief
December 2024
Department of Human Oncology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792, USA.
Purpose: Integrated MRI and linear accelerator systems (MR-Linacs) provide superior soft tissue contrast, and the capability of adapting radiotherapy plans to changes in daily anatomy. In this dataset, serial MRIs of the abdomen of patients undergoing radiotherapy were collected and the luminal gastro-intestinal tract was segmented to support an online segmentation algorithm competition. This dataset may be further utilized by radiation oncologists, medical physicists, and data scientists to further improve auto segmentation algorithms.
View Article and Find Full Text PDFImplementation Strategy for Artificial Intelligence in Radiotherapy: Can Implementation Science Help?
JCO Clin Cancer Inform
December 2024
Tilburg School of Economics and Management, Tilburg University, Tilburg, the Netherlands.
Purpose: Artificial intelligence (AI) applications in radiotherapy (RT) are expected to save time and improve quality, but implementation remains limited. Therefore, we used implementation science to develop a format for designing an implementation strategy for AI. This study aimed to (1) apply this format to develop an AI implementation strategy for our center; (2) identify insights gained to enhance AI implementation using this format; and (3) assess the feasibility and acceptability of this format to design a center-specific implementation strategy for departments aiming to implement AI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!